Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

Completed · Phase 3

Conditions studied: Osteoarthritis, Knee

In brief

This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.

Key facts

Study ID
NCT00139295
Run by
Genzyme, a Sanofi Company
Starts
2004-10-01
Expected to finish
2007-09-01
Last updated by the study team
2014-02-05

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.